Evelo Biosciences begins dosing in phase 2 trial of EDP1815 for eczema
18 February 2022 - 12:42AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Evelo Biosciences (NASDAQ:EVLO)
Historical Stock Chart
From Apr 2024 to May 2024
Evelo Biosciences (NASDAQ:EVLO)
Historical Stock Chart
From May 2023 to May 2024